1.Exercise-induced angiogenesis and lymphangiogenesis: A potential therapeutic tool to fight aging and disease.
Jizong JIANG ; Yongjun ZHENG ; Rui WANG ; Hao YANG ; Shihui ZANG ; Emeli CHATTERJEE ; Guoping LI ; Dragos CRETOIU ; Cuimei ZHAO ; Junjie XIAO
Chinese Medical Journal 2025;138(20):2552-2587
Aging is an inevitable, physiological process of the human body, leading to deterioration in bodily function and increased susceptibility to various diseases. Effective endogenous therapeutic strategies for anti-aging and related diseases remain limited. Exercise confers multifaceted benefits to physical health by augmenting osteogenic and myogenic processes, enhancing cardiovascular and nervous system function, and attenuating chronic inflammation. Angiogenesis and lymphangiogenesis play pivotal roles in anti-aging, tissue repair, and immune response modulation, underscoring their potential as therapeutic targets for age-related diseases. Modulating angiogenic and lymphangiogenic pathways may provide a promising strategy for mitigating vascular decline and immune system dysfunction associated with aging. Exercise-induced endogenous angiogenesis and lymphangiogenesis can exert beneficial effects on physiological function, thereby representing a potential therapeutic paradigm for combating age-related decline and diseases. This review offers a thorough summary of the present knowledge regarding angiogenesis and lymphangiogenesis induced by exercise, encompassing the underlying mechanisms and the effects in different organs. In addition, it explores the potential of physical activity as a non-pharmacological intervention for anti-aging strategies and disease management, offering novel insights into the intersection of physical activity, aging, and disease progression.
Humans
;
Lymphangiogenesis/physiology*
;
Aging/physiology*
;
Exercise/physiology*
;
Animals
;
Neovascularization, Physiologic/physiology*
;
Angiogenesis
2.Research progress of ETS-1 in inflammatory bowel disease and colitis-associated colorectal cancer
Xufan SUN ; Guiyuan JIN ; Cuimei MA ; Yan WANG ; Huihui ZHOU ; Guangxi ZHOU
Chinese Journal of Inflammatory Bowel Diseases 2024;08(2):164-168
ETS proto-oncogene 1 (ETS-1) is a member of ETS transcription factor family and plays essential roles in tumorigenesis and inflammation. ETS-1 promotes the development of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC) by inducing inflammation, destroying the intestinal epithelial cell barrier, and increasing the invasiveness of cancer cells. This article reviews the research progress of ETS-1 in IBD and CAC in order to investigate the pathogenesis and underlying treatment targets of IBD and CAC.
3.Research progress of ETS-1 in inflammatory bowel disease and colitis-associated colorectal cancer
Xufan SUN ; Guiyuan JIN ; Cuimei MA ; Yan WANG ; Huihui ZHOU ; Guangxi ZHOU
Chinese Journal of Inflammatory Bowel Diseases 2024;08(2):164-168
ETS proto-oncogene 1 (ETS-1) is a member of ETS transcription factor family and plays essential roles in tumorigenesis and inflammation. ETS-1 promotes the development of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC) by inducing inflammation, destroying the intestinal epithelial cell barrier, and increasing the invasiveness of cancer cells. This article reviews the research progress of ETS-1 in IBD and CAC in order to investigate the pathogenesis and underlying treatment targets of IBD and CAC.
4.The influence of carnosine in expression levels of bcl-2 and bax after focal cerebral ischemia in rats
Jie ZHU ; Qian MA ; Xin WANG ; Cuimei LIU ; Aihong WANG
Tianjin Medical Journal 2015;(3):259-262
Objective To explore the effect of carnosine in the expression of B cell lymphomal/leukemia-2 (bcl-2) and bcl-2-associated X protein (bax) after focal cerebral ischemia in rats. Methods Thirty male SD rats (SPF scale) were ran?domly divided into 3 groups:sham-operated group, model group and carnosine treated group (n=10 for each group). The mid?dle cerebral artery occlusion model (MCAO) was induced in model group and carnosine treated group. Rats were received carnosine [1 000 mg/(kg·d), orally] in carnosine treated group, and the other rats were received the same volume of normal sa?line (NS) in shame-operated group and model group. The neurological deficit score was used to evaluate the neurological function at 24 h and 72 h after MCAO. Morphological changes were observed by HE staining. TCC staining was used to label infarct volume, and immunohistochemistry was used to detect the expression of bcl-2 and bax. Results Compared with model group, the score of neurological function and infarct volume were significantly declined in carnosine treated group at 72 h after injury (P<0.05 or P<0.01). The changes of ischemic impairment were lighter in carnosine treated group than that of model group. Compared with sham-operated group, the expression levels of bcl-2 and the ratio of bcl-2/bax were de?creased while the expression of bax was increased in model group (P<0.05). Compared with model group, carnosine could sig?nificantly increase the expression of bcl-2 and the ratio of bcl-2/bax, and reduce the expression of bax (P<0.01 or P<0.05). Conclusion Carnosine can enhance bcl-2 expression, decrease bax expression and increase the ratio of bcl-2/bax, which is likely to be one of the mechanisms of neuroprotection.
5.Rho Kinase Activity Predicts Left Ventricular Remodeling in Patients With Acute ST-segment Elevation Myocardial Infarction
Cuimei ZHAO ; Li LI ; Luying PENG ; Jinfa JIANG ; Wenjun XU ; Wenlin MA ; Jiahong XU
Chinese Circulation Journal 2014;(11):867-870
Objective: To investigate the predictive value of an early inflammatory response factor, Rho kinase activity for left ventricle remodeling (LVR) in patients with acute ST-segment elevation myocardial infarction (STEMI).
Methods: A total of 120 acute STEMI patients treated in our hospital from 2010-10 to 2013-06 were studied, all patients were ifrst time received primary percutaneous coronary intervention (PCI) with stent implantation. Rho kinase activity and B-type natriuretic peptide (BNP) were measured before PCI, echocardiography was conducted at 24 hours and 12 months after STEMI respectively to clarify LVR diagnosis. The patients were divided into 2 groups as LVR group, n=97 and Non-LVR group, n=23, the above indexes were compared between 2 groups.
Results: The level of Rho kinase was higher in LVR group than that in Non-LVR group, P<0.001, after adjustment, Rho kinase was the independent predictor for LVR (OR 3.36, 95%CI 2.01–5.78, P<0.001). The ROC of Rho kinase was 0.88 (95%CI 0.82–0.94) and the ROC of BNP was 0.54 (95%CI 0.41–0.70).
Conclusion: High Rho kinase activity could predict LVR in acute STEMI patients with primary PCI and stent implantation.
6.Influence of Three High-level Disinfectants Sterilization on Cauterization of Dental Instruments
Chunmei MA ; Cuimei LIU ; Shenpo YUAN
Chinese Journal of Nosocomiology 2006;0(02):-
OBJECTIVE To evaluate the influence of three high-level chemical disinfectants for sterilization on cauterization of dental instruments.METHODS The measuring methods for disinfectants on cauterization of metal instruments,and usage indications for disinfectants followed Technical Standard for Disinfection published in 2002 by the Ministry of Health.Fourteen kinds of small instruments(grouped by 4 different metal materials) were analyzed on receipt and after sterilization by three high-level disinfectants(2% glutaraldehyde,chlorine dioxide, and symclosene),using cauterization rate.RESULTS Three high-level disinfectants had different cauterization rates,the cauterization rate was affected by concentration of disinfectant,sterilizing time,and morphology of instruments.The cauterization of chlorine dioxide was the strongest,followed by symclosene(trichloroisocyanuric acid),and then 2% glutaraldehyde.CONCLUSIONS In clinical sterilization,different materials of small instruments need proper disinfectants,concentration and sterilizing time for decreasing their cauterization.

Result Analysis
Print
Save
E-mail